EFPIA - NEWSLETTER

Trouble reading this email? View it in your browser


		EFPIA Newsletter 25 January 2018

IMI2 Call 14 draft topics published

IMI2 Call 14 will be launched in March, and draft topics are already available on the IMI Future topics page. Please feel free to disseminate.

Call 14 will include four topics, focused on immunology, digital health and clinical trials, as well as machine-leaning:

The official launch is expected on 15 March 2018, with the submission deadline for short proposals on 14 June 2018.

For any additional detail, please contact science-policy@efpia.eu.

Events

17012018 Digital Health - Improving Prevention, Prediction and Care A Global, European and...
31 January 2018 (Allianz Forum, Berlin, Germany)

An event organised by German Healthcare Partnership, Merck and vfa Read more

13122017 European Conference on Rare Diseases and Orphan Products
10 May 2018 (Messe Wien Congress Center, Vienna, Austria)

The largest multi-stakeholder gathering in Europe for the rare disease community Read more

06122017 4th European Conference on Clinical Research
26 February 2018 (Vienna, Austria)

A EUCROF conference Read more

25012018 Gaining the Benefits of Improved Health Data Quality
05 March 2018 (Paris, France)

A two-day workshop run by the i~HD Hospital Network of Excellence and Data Quality Task Force Read more

What we are reading

Pulling Together To Thwart A Silent Killer
On 22 January 2018 (IFPMA)

As we start 2018, those of us in the healthcare sector are anticipating greater progress in global health. Without... Read more

A New Ecosystem Approach to Fight Antibiotic Resistance
On 24 January 2018 (DRIVE-AB)

An international consortium managed by the University of Geneva and AstraZeneca issues final report on its research-based... Read more

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
E-mail:Communications@efpia.eu